LEO Pharma reveal positive results from delgocitinib research
Phase 3 clinical trial focuses on adults with moderate-to-severe chronic hand eczema
Novadip reveals results from severe bone non-union trial
Study involves candidate NVD-003 and the treatment of lower limb trauma
Catalent completes cell therapy manufacturing facilities in Belgium
Facility represents one of the largest commercial-scale operations in the world
Positive results for Amphera’s MesoPher cell therapy
Treatment demonstrated significant survival data in addition to a sustained safety profile
Kidney Research UK concerned by NICE process
Organisation believes the guidance would leave renal patients with no effective treatment outside hospital
Novartis joins Cancer Research UK on rare cancers study
DETERMINE trial aims to discover if current treatments could benefit patients with other cancer types
Scottish Medicines Consortium agrees to use of Rinvoq
Therapy will now treat adults across Scotland with moderate rheumatoid arthritis
Contact
c o n n e c t
We help you make confident decisions based on data
Phone Number
+33 (0) 139 141 301
Address
16 Rue Washington, 75008 Paris
Members of:
We follow the guidelines of:
